Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XJH05 Ointment in Plaque Psoriasis
NCT07780929Recruiting
- Sponsor
- Xijing Hospital
- Start
- Nov 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Trial of XJH05 in plaque psoriasis (2 arms), sponsored by Xijing Hospital. Primary endpoints: Changes in the phenotypes of psoriasis lesions using dermoscopy at 4 weeks, Physician's Global Assessment at 4 weeks and 2 more. Started Nov 2025; status: recruiting.
02
Drugs
XJH05
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07780929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07780929.